CRISPR Therapeutics stays a Hold as CASGEVY launch lags; watch cash burn, revenue delays, and CTX310/CTX611 catalysts for ...
Michael Saylor’s Strategy Inc. bought nearly $170 million in Bitcoin, roughly half of which was financed with perpetual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results